Licensed vaccine
FluMist
FDA-licensed vaccine · MedImmune, LLC · STN 125020
Key facts
| Trade name | FluMist |
|---|---|
| Proper name | Influenza Vaccine, Live, Intranasal (Trivalent, Types A and B) |
| Manufacturer | MedImmune, LLC |
| Submission tracking number (STN) | 125020 |
| FDA product areas | Biologics, Vaccines |
| Recent FDA documents | September 20, 2024 Approval Letter - FluMist, August 6, 2024 Approval Letter - FluMist, Package Insert and Information for Patients - FluMist, July 9, 2020 Approval Letter - FluMist, Supporting Documents older than three years - FluMist |
| FDA page updated | Sep 26, 2024 |
| FDA product page | fda.gov |
At a glance
- 1–9 FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: